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Abstract 
Background: Rotavirus vaccines have poor efficacy in infants from low‑ and middle‑income countries. Gut microbi‑
ota is thought to influence the immune response to oral vaccines. Thus, we developed a gnotobiotic (Gn) pig model 
of enteric dysbiosis to study the effects of human gut microbiota (HGM) on immune responses to rotavirus vaccina‑
tion, and the effects of rotavirus challenge on the HGM by colonizing Gn pigs with healthy HGM (HHGM) or unhealthy 
HGM (UHGM). The UHGM was from a Nicaraguan infant with a high enteropathy score (ES) and no seroconversion 
following administration of oral rotavirus vaccine, while the converse was characteristic of the HHGM. Pigs were vac‑
cinated, a subset was challenged, and immune responses and gut microbiota were evaluated.
Results: Significantly more rotavirus‑specific IFN‑γ producing T cells were in the ileum, spleen, and blood of HHGM 
than those in UHGM pigs after three vaccine doses, suggesting HHGM induces stronger cell‑mediated immunity than 
UHGM. There were significant correlations between multiple Operational Taxonomic Units (OTUs) and frequencies of 
IFN‑γ producing T cells at the time of challenge. There were significant positive correlations between Collinsella and 
CD8+ T cells in blood and ileum, as well as CD4+ T cells in blood, whereas significant negative correlations between 
Clostridium and Anaerococcus, and ileal CD8+ and CD4+ T cells. Differences in alpha diversity and relative abun‑
dances of OTUs were detected between the groups both before and after rotavirus challenge.
Conclusion: Alterations in microbiome diversity and composition along with correlations between certain microbial 
taxa and T cell responses warrant further investigation into the role of the gut microbiota and certain microbial spe‑
cies on enteric immunity. Our results support the use of HGM transplanted Gn pigs as a model of human dysbiosis 
during enteric infection, and oral vaccine responses.
Keywords: Enteric dysbiosis, Gnotobiotic pig, Rotavirus, Vaccine, Enteric immunity
© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
Rotavirus gastroenteritis accounted for approximately 
37% of all diarrhea-related deaths and 5% of all deaths 
in children less than 5 years of age; in all, rotavirus killed 
approximately 453,000 children in 2008, mostly from 
low-middle income countries (LMICs) [1, 2]. Oral vac-
cines for rotavirus, poliovirus, cholera and shigellosis are 
less efficacious in children from LMICs than in children 
from higher income countries [3, 4]. Specifically regard-
ing oral rotavirus vaccination, the two commercially 
available vaccines (RotaTeq® and Rotarix®) only have 
39–70% efficacy, with an average of 50–60% efficacy in 
LMICs; whereas rotavirus vaccines are 80–90% effective 
in high-income countries [3, 5–7]. Differences in rotavi-
rus vaccine efficacy may be due to a combination of fac-
tors including environmental enteric dysfunction (EED), 
variations in the gut microbiome, an altered gut micro-
biota composition (dysbiosis), high maternal antibody 
titers transferred through the placenta or breast milk, 
malnutrition, or influence of concurrent enteropathogens 
[3, 4, 6–8].
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Environmental enteric dysfunction, also known as envi-
ronmental enteropathy is a structural and functional dis-
order of the small intestine that is most frequently seen 
in children from low income settings [9]. EED leads to 
gut barrier disruption, nutrient malabsorption, impaired 
gut immune function, and ultimately, oral vaccine fail-
ure, growth stunting, and delayed cognitive development 
[9–11]. However, children with EED do not always have 
diarrhea [10]. Histologic features include villous blunt-
ing, crypt hyperplasia, and lymphocytic infiltration of 
the epithelium and lamina propria in the small intestine 
[9]. The cause of this condition is unknown, but theories 
include constant exposure to enteropathogens in food, 
water, or the environment, imbalance of gut microbiota, 
and an altered immune response triggered by intestinal 
microbes [4, 9, 10].
The gastrointestinal microbiota is important for the 
development of enteric immunity, prevention of enter-
opathogen colonization, and utilization of dietary energy 
[4, 12]. The composition of the gut microbiota in chil-
dren is influenced by the method of delivery (vaginal or 
C-section), environmental hygiene, and nutritional sta-
tus [4]. Studies have shown that the composition of gut 
microbiota is significantly different between African and 
northern European infants, and between malnourished 
and well-nourished children [10, 12, 13].
The goal of this study was to create a gnotobiotic (Gn) 
pig model of human enteric dysbiosis to evaluate the 
influence of the gut microbiota on immune responses 
to an attenuated human rotavirus vaccine (AttHRV). 
Since pigs and humans share high genomic and protein 
sequence homologies, an omnivorous diet, colonic fer-
mentation, and similar immune systems, pigs serve as 
valuable models in biomedical research [14]. To this 
effect, the neonatal Gn pig model is a proven model of 
human rotavirus disease and immunity [15]. Protection 
against rotavirus diarrhea in the Gn pig model is posi-
tively correlated with frequencies of intestinal IFN-γ pro-
ducing T cells, rotavirus-specific serum IgA, intestinal 
IgA and intestinal IgG antibody titers, and IgA antibody 
secreting cells in the intestine [16–18].
The study of microbiota on virus life cycle is facili-
tated by the germ-free condition in Gn pigs [19–22]. In 
addition, our previous studies of human gut microbiota 
(HGM) transplanted Gn pigs demonstrated that HGM 
from a healthy C-section delivered infant was able to 
colonize newborn Gn pig intestine and similar micro-
biota was observed between HGM from the infant and 
colonized Gn pigs [20, 21]. In this study we attempted 
to develop a Gn pig model of human enteric dysbiosis 
by colonizing Gn pigs with unhealthy HGM (UHGM). 
UHGM designates the HGM samples from children with 
evidence of gut inflammation and permeability (based 
on enteropathy scores (ES) and an impaired immune 
response to the rotavirus vaccine RV5 (RotaTeq®), sug-
gesting an unhealthy gut. HGM from children with low 
ES and a robust immune response to RV5, suggesting a 
normal gut, was designated as healthy HGM (HHGM). 
We hypothesized that HHGM in Gn pigs would induce 
a stronger immune response after vaccination than the 
dysbiosis pigs, and that certain components of the HGM 
may be correlated with impaired immune responses.
Results
Antibody response in HHGM and UHGM pigs
Healthy HGM and UHGM samples were orally inocu-
lated into a subset of newborn Gn pigs, respectively. 
After AttHRV inoculation and virulent HRV (VirHRV) 
challenge, antibody titers were measured in small intes-
tinal contents (SIC), large intestinal contents (LIC), and 
serum. Rotavirus-specific immunoglobulin titers in intes-
tinal contents from HHGM pigs consistently trended 
higher than titers from the UHGM pigs, before and after 
VirHRV challenge, including IgG and IgA in SIC and 
IgA in LIC (Fig.  1a). However, rotavirus-specific IgA, 
IgG, and virus neutralizing antibody responses in serum 
did not differ between the two groups at any time point 
(Fig. 1b). These data suggest that HHGM could have an 
influence toward a stronger mucosal immune response to 
oral rotavirus vaccine than UHGM.
Virus specific effector T cell response
Frequencies of IFN-γ+CD8+  T cells among total 
CD8+ T cells in the ileum, spleen, and blood of HHGM 
pigs were significantly higher than those in UHGM 
pigs at the time of VirHRV challenge (Fig. 2). Frequen-
cies of IFN-γ+CD4+ T cells among total CD4+ T cells 
in the ileum and blood were also significantly higher in 
HHGM pigs than in UHGM pigs at the time of VirHRV 
challenge. After challenge, IFN-γ+  CD8+  and IFN-
γ+CD4+  T cell responses did not differ significantly 
between the two groups in any tissue. The data dem-
onstrate that the AttHRV vaccine induced significantly 
stronger anti-viral effector T cell immune responses in 
pigs colonized with HHGM than those with UHGM. 
The significantly higher virus-specific effector T cell 
responses at the time of challenge were associated with 
increased protection against rotavirus shedding and 
clinical signs (Fig. 2; Table 1).
Clinical signs and virus shedding
After challenge with VirHRV, HHGM pigs had signifi-
cantly reduced incidence and shorter duration of viral 
shedding, and lower mean peak virus titer than UHGM 
pigs (Table 1). HHGM pigs had a slightly lower incidence, 
delayed onset, shorter duration of diarrhea, and lower 
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cumulative diarrhea score compared to the UHGM pigs. 
These results suggest that HHGM is associated with less 
severe clinical signs and viral shedding than UHGM in 
vaccinated pigs subsequently challenged with VirHRV, 
indicating that HHGM facilitates the development of a 
stronger protective immunity.
Microbiome analysis
Alpha diversity, measured by Shannon index, phylo-
genic diversity, observed species, and Chao 1 were com-
pared between HHGM and UHGM pig groups (Table 2). 
Measurements of alpha diversity in HHGM pigs were 
significantly lower than those in UHGM pigs at post-
inoculation day (PID) 28 and post-challenge day (PCD) 
7. In addition, alpha diversity measurements decreased in 
HHGM pigs from PID28 to PCD7. There were no signifi-
cant differences before or after challenge for the UHGM 
pigs. These results suggest that VirHRV challenge caused 
a greater disruption to the microbiota in HHGM pigs 
than in UHGM pigs. Beta diversity analysis was visu-
alized with a PCoA plot based on unweighted UniFrac. 
Regardless of the time point, the microbiota from pigs 
with HHGM clustered in one group while samples from 
UHGM pigs formed another group (Fig. 3).
In HGM transplanted pigs, phyla represented in 
UHGM pigs were similar to those in the human infant 
samples, with Firmicutes being the most abundant. Fir-
micutes was also the most abundant phylum in the 
healthy human infant stool sample. Conversely, Proteo-
bacteria or Bacteroidetes was the most abundant phyla 
in HHGM pigs with Firmicutes being second or third in 
mean relative abundance (Fig. 4). There were significantly 
more Firmicutes in UHGM pigs than in HHGM pigs at 
PID28. After VirHRV challenge on PCD7, the phyla, Fir-
micutes, Proteobacteria and Tenericutes had significantly 
higher mean relative abundance in the UHGM pigs while 
mean relative abundance of Bacteroidetes was signifi-
cantly higher in HHGM pigs. When evaluating micro-
biome shifts in HHGM pigs before and after VirHRV, 
Firmicutes, Proteobacteria and Verrucomicrobia were 
shown to be significantly decreased while Bacteroidetes 
significantly increased in mean relative abundance. There 
Fig. 1 Rotavirus‑specific antibody responses. Rotavirus‑specific IgG and IgA antibody responses in small and large intestinal contents (a) and IgG, 
IgA and virus neutralizing antibody response in serum (b). Error bars are represented as standard error of mean. Kruskal–Wallis rank sum test was 
used for comparisons. There are no significant differences between the groups. SIC small intestinal contents; LIC large intestinal contents; PID post‑
inoculation day; PCD post‑challenge day
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were no significant changes in gut phyla composition in 
UHGM between pre- and post-VirHRV challenge sam-
ples (Fig. 5).
Differences at the genera level were also evaluated 
between the two groups. On PID28, the mean relative 
abundance was significantly higher for the following 
Fig. 2 Frequencies of IFN‑γ producing CD8+ and CD4+ T cells. Frequencies of IFN‑γ producing CD8+ and CD4+ T cells among total 
CD3+CD8+ and CD3+CD4+ cells on PID28/PCD0 (upper panel) and PCD7 (lower panel) in ileum, spleen and blood of HHGM verses UHGM colo‑
nized pigs. Error bars indicate standard errors of the mean. Asterisks indicate significant differences when compared to PM25 pigs (Kruskal–Wallis 
rank sum test, p < 0.05; n = 5–7)
Table 1 Clinical signs and rotavirus fecal shedding in Gn pigs after VirHRV challenge
ELISA enzyme-linked immunosorbent assay, CCIF cell culture immunofluorescent assay, FFU fluorescence forming unit
* Fisher’s exact test was used for comparisons. Asterisk indicate significant differences among groups (n = 6–7; p < 0.05)
** Kruskal–Wallis rank sum test was used for comparisons. No statistically significant differences were observed between the groups
a  Pigs with daily fecal scores of ≥2 were considered diarrheic. Fecal consistency was scored as follows: 0, normal; 1, pasty; 2, semiliquid; and 3, liquid
b  In the groups where some but not all pigs had diarrhea or shedding, the onset of diarrhea or shedding for non-diarrheic/shedding pigs was designated as 8 for 
calculating the mean days to onset
c  Mean cumulative score calculation included all the pigs in each groups
d  Standard error of the mean
e  For days of diarrhea and virus shedding, if no diarrhea or virus shedding until the euthanasia day (PCD7), the duration days were recorded as 0
Group N Clinical signs Fecal virus shedding (by CCIF and/or ELISA)
% with diar‑
rheaa,*
Mean days 
to onsetb,**
Mean dura‑
tion dayse,**
Mean cumula‑
tive scorec,**
% shedding 
virus*
Mean days 
to onsetb,**
Mean dura‑
tion dayse,**
Mean peak titer 
(FFU/ml)
HHGM 7 57.1 4.3 (0.23)d 1.3 (0.57)d 7.7 (0.77)d 42.85* 1.7 (0.2)d 1.6 (0.7)d 657.4
UHGM 6 83.3 2.3 (1.1) 2.0 (0.89) 11.2 (1.2) 100* 2.4 (0.3) 3.0 (0.63) 1683.7
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OTUs in the HHGM group compared to the UHGM 
group; Enterococcus, Collinsella, Stenotrophomonas, 
Pseudomonas, and unclassified members of Lactobacil-
lales and Enterococcaceae. The mean relative abun-
dance of the following OTUs were significantly higher 
in UHGM pigs compared to HHGM pigs on PID28; 
Clostridium, Streptococcus, Ruminococcus, Anaerococ-
cus, Propionibacterium, Blautia, and unclassified mem-
bers of Clostridiales, Bacillales, and Lachnospiraceae 
(Figs. 6, 7).
At PCD7, mean relative abundance was significantly 
higher for Bacteroides, Collinsella, and unclassified mem-
bers of Clostridiaceae and Erysipelothichaceae in HHGM 
pigs compared to that in UHGM pigs. UHGM pigs had 
a significantly higher mean relative abundance of Rumi-
nococcus, Streptococcus, Clostridium, Bifidobacterium, 
Staphylococcus, Turicibacter, Propriobacterium, Haemo-
philus, Moraxella, Blautia, Prevotella, Granulicatella, 
and unclassified members of Enterobacteriaceae, Bacilla-
les, Lachnospiraceae, and Clostridiales than the HHGM 
pigs (Figs. 6, 7).
Spearman’s correlation coefficients were determined 
for frequencies of rotavirus-specific IFN-γ producing T 
cells in ileum, spleen, and blood, and OTUs at the genus 
level on PID28 (PCD0) and PCD7 (Table 3). There were 
significant positive correlations between Collinsella and 
CD8+  T cells in blood and ileum, as well as CD4+  T 
cells in blood at PCD0. At PCD0, significant negative 
correlations existed between Clostridium and Anaero-
coccus, and ileal CD8+ and CD4+ T cells. At this time 
point, CD8+ T cells in blood were negatively correlated 
with Propionibacterium, Blautia, and an unclassified 
member of Bacillales, while CD4+ T cells in blood were 
negatively correlated with 2 unclassified members of 
Clostridiales.
At PCD7, there were significant positive correla-
tions between unclassified members of Clostridiales 
and Mycoplasmataceae and ileal CD8+  T cells. Splenic 
CD8+  and CD4+  T cells and ileal CD8+  T cells were 
negatively correlated with Anaerococcus. A negative cor-
relation also existed between splenic CD4+  T cells and 
Staphylococcus.
These data suggest the influence of specific bacterial 
OTUs on the vaccine-induced T cell responses, as well as 
the selective impact of IFN-γ producing T cell responses 
on the gut microbiome. Further investigations are needed 
to determine which OTUs are most important for influ-
encing the immune response and the mechanism by 
which they do so.
Table 2 Mean alpha diversity parameters in gut microbiome of HGM colonized Gn pigs
** Kruskal–Wallis rank sum test was used for comparisons. p < 0.05 is considered significant
HHGM Comparison between time points Comparison between groups
PID28 PCD7 p** PID28 HHGM UHGM p
Shannon index 2.366 1.236 0.009 Shannon index 2.366 2.743 0.006
Phylogenetic diversity 6.806 6.108 0.016 Phylogenetic diversity 6.806 6.580 0.855
Observed species 92.460 65.180 0.009 Observed species 92.460 90.550 0.855
Chao 1 168.399 125.946 0.009 Chao 1 168.399 189.092 0.201
UHGM Comparison between time points Comparison between groups
PID28 PCD7 p PCD7 HHGM UHGM p
Shannon index 2.743 2.780 0.749 Shannon index 1.236 2.780 0.006
Phylogenetic diversity 6.580 6.988 0.262 Phylogenetic diversity 6.108 6.988 0.045
Observed species 90.550 102.583 0.173 Observed species 65.180 102.583 0.006
Chao 1 189.092 206.175 0.631 Chao 1 125.946 206.175 0.006
Fig. 3 PCoA plot of the microbial communities in the large 
intestinal contents of Gn pigs. Communities were plotted based 
on unweighted UniFrac. Blue dots represent HHGM and red dots 
represent UHGM
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Enteropathy biomarkers, histopathology, pig weights
Concentrations of α-1-antitrypsin, myeloperoxidase and 
regenerating islet derived protein 1 beta (REG1B) in SIC 
and LIC were measured using porcine specific ELISAs. 
Alpha-1-antitrypsin is a serum protein that is not pre-
sent in stool unless there increased gut permeability [9]. 
Myeloperoxidase is released from activated neutrophils 
and is an indicator of inflammation [9]. REG1B is a pro 
proliferative antiapoptotic protein secreted by damaged 
enterocyte and is involved in tissue repair, cell growth 
and regeneration [23, 24]. There were no significant dif-
ferences between the two pig groups at PID28 or PCD7 
(Additional file 1: Table S2). When compared to those of 
the two human infants (Table 4), the α-1-antitrypsin and 
myeloperoxidase concentrations were even lower than 
the HHGM, suggesting that no enteropathy developed in 
the pigs.
Histopathologic evaluation of villus length, crypt 
depth, villus to crypt ratio, villus width, and mitotic index 
in duodenum, jejunum, and ileum did not reveal any sig-
nificant differences between the two groups at the two 
time points (Additional file 1: Table S3; Additional file 2: 
Figure S1, Additional file  3: Figure S2, Additional file  4: 
Figure S3). Thus, the enteropathy status of the UHGM 
infant donor, as indicated by the higher ES of the UHGM 
samples, was not recapitulated in the UHGM-colonized 
Gn pigs.
Weights of pigs did not differ between the groups at any 
of the time points (Additional file 1: Table S4). This sug-
gests the microbiota did not differentially affect nutrient 
assimilation or growth. The lack of significant differences 
between the groups in regards to enteropathy biomark-
ers, histopathology, or weight indicates enteropathy did 
not develop in this Gn model within the timeframe of 
this experiment.
Discussion
In this study we demonstrated that Gn pigs colonized 
by UHGM can serve as a model system for enteric dys-
biosis and impaired immunity. We used this neonatal 
pig model system to evaluate the effects of gut microbi-
ota on immune responses to oral rotavirus vaccination. 
We also evaluated the impact of rotavirus challenge on 
the gut microbiota. In this model system, the only vari-
able was the different HGM; thus any observed differ-
ence in the results could be attributed to differences in 
the gut microbiota. We demonstrated that pigs colonized 
with HHGM had a significantly stronger effector T cell 
Fig. 4 Mean relative abundance of phyla in the microbial community of large intestinal contents. Mean relative abundance of phyla in the micro‑
bial community of large intestinal contents of HGM‑colonized Gn pigs before HRV challenge (PID28/PCD0) and postchallenge (PCD7) compared to 
infant HGM. Numbers represent the single stool sample from infant HGM and averages for the pig groups (n = 5–6)
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immune response to vaccination compared to UHGM 
pigs. Additionally, we found significant correlations 
between some bacterial OTUs and frequencies of effec-
tor T cells, and we also observed differences in the gut 
microbiome composition and diversity both before and 
after VirHRV challenge.
When the two groups were compared, UHGM had 
weaker virus-specific T cell immune responses to 
AttHRV and trended lower rotavirus-specific antibody 
titers in intestinal contents. These data indicate that 
HHGM facilitated a stronger adaptive immune response 
to oral rotavirus vaccine than did UHGM. Evidently, 
UHGM pigs had higher viral shedding and more severe 
clinical signs compared to HHGM pigs after challenge 
with VirHRV.
The rotavirus challenge caused significant decreases 
in alpha diversity indices in the HHGM pigs, while no 
significant changes were detected in UHGM pigs. The 
decreased alpha diversity in HHGM pigs after VirHRV 
challenge was expected. A study evaluating microbi-
ome and diarrhea found that diarrhea was associated 
with decreased phylogenetic diversity [25]. Although no 
samples were available for time points after PCD7, it is 
expected, given our data on enteropathy biomarkers, 
that diversity of HHGM pigs would return to normal lev-
els. The lack of significant differences in alpha diversity 
parameters in UHGM pigs from PID28 to PCD7 may be 
due to an already abnormal microbiome and/or previous 
exposure to rotavirus based on pre-vaccination serum 
IgA titer in the infant donor.
The mean relative abundance of phyla between UHGM 
pig LIC samples and infant stool sample (PM25) was sim-
ilar, which was as expected. However, HHGM pig sam-
ples differed from their infant donor (SV14). Community 
structure may have been different between the human 
and pigs because of influence of different environments, 
differences in diet, lack of natural microbial succession 
in the pigs, or differences in host genetics [26]. The phy-
lum and genus level differences between HHGM and 
UHGM pigs at both time points warrant further study to 
assess the influences of these OTUs on the host immune 
response. In HHGM pigs, after VirHRV challenge, there 
was a decrease in the relative abundance of Firmicutes, 
similar to previous observations [21]. Although we did 
not sample pigs without AttHRV vaccination, human 
studies have shown that rotavirus vaccination does not 
Fig. 5 Relative abundance of phyla in the microbial community of large intestinal contents of individual pigs. Relative abundance of phyla in the 
microbial community of large intestinal contents of individual HGM‑colonized Gn pigs before VirHRV challenge (PID28/PCD0) and postchallenge 
(PCD7). The HHGM human sample is included for reference in each panel. HHGM human is the sample from child SV14 and UHGM human is the 
sample from child PM25
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have any major effects on the gut microbiota of children 
[27, 28]. Similar to a human study, HHGM pigs had an 
increased mean relative abundance of Bacteroides after 
rotavirus infection [29]. Bacteroides and Lactobacillus 
species have been shown to modify cell-surface glycans 
in human intestinal cultured cells, effectively blocking 
rotavirus infection [30]. This may partially explain why 
HHGM pigs had decreased viral shedding when com-
pared to UHGM pigs. In agreement with a previous 
study, we also observed a decrease in levels of Strepto-
coccus in HHGM pigs after the rotavirus challenge [21]. 
There is limited data on mechanisms by which micro-
biota directly influences enteric virus infectivity. Micro-
biota may modify the cell surface or bind to pathogens. 
In vitro experiments have demonstrated soluble factors 
from Bacteroides thetaiotaomicron and Lactobacillus 
casei can increase cell surface galactose and block rota-
virus infection [30]. Poliovirus binds bacterial surface 
polysaccharides, which enhances virion stability and cell 
attachment, and may enhance transmission [31]. Gnoto-
biotic pigs colonized with E. coli Nissle 1917 (EcN) had 
lower viral shedding titers, which the authors speculated 
was because EcN bound to HRV particles [32].
There were significant positive and negative cor-
relations between OTUs and IFN-γ producing T cell 
responses in the ileum, blood, and spleen. The bio-
logical relevance of these findings needs to be explored 
further. Previous studies have shown that the HGM 
promotes development of the neonatal immune sys-
tem as evidenced by the significantly enhanced IFN-γ 
producing T cell response and decreased regulatory T 
cells in AttHRV-vaccinated pigs when comparing HGM 
colonized Gn pigs to non-HGM colonized Gn pigs [20]. 
Human studies have shown correlations between micro-
biome components and response to vaccination. In Bang-
ladeshi infants, Actinobacteria, Coriobacteriaceae, and 
Bifidobacterium abundance were positively correlated 
with T cell responses to oral polio vaccine, while Pseuod-
monadales, Clostridiales, and Enterobacteriales had a 
negative correlation [33]. Concurring with the human 
study, in this present study Collinsella, a member of the 
Coriobacteriaceae, was strongly and positively correlated 
with intestinal and circulating rotavirus specific IFN-γ 
producing CD8+  T cell responses, which are known to 
correlate with protection against rotavirus diarrhea [18].
We successfully generated a model of dysbiosis, but 
not enteropathy. There were no differences between the 
pig groups in regards to gut permeability, assessed by 
α−1-antitrypsin, gut inflammation, assessed by myelop-
eroxidase or epithelial regeneration assessed by REG1B. 
Fig. 6 Relative abundance of specified bacterial taxa in the microbial community of large intestinal contents in HHGM pigs. Relative abundance of 
order, family, or genera of bacteria in the large intestinal contents at specified time points in HHGM pigs. Bars to the right of PID 28 are pigs eutha‑
nized on PID 28. Bars to the right of PCD 7 are pigs euthanized on PCD 7
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Fig. 7 Relative abundance of specified bacterial taxa in the microbial community of large intestinal contents in UHGM pigs. Relative abundance of 
order, family, or genera of bacteria in the large intestinal contents at specified time points in UHGM pigs. Bars to the right of PID 28 are pigs eutha‑
nized on PID 28. Bars to the right of PCD 7 are pigs euthanized on PCD 7
Table 3 Spearman’s rank correlation coefficients between  specified OTUs and  rotavirus-specific IFN-γ+CD8+  or IFN-
γ+CD4+ T cells among all Gn pigs
OTU Tissue T cell type ρ p value adj. p value
Positive correlations
 PCD0 Collinsella Ileum CD8+ 0.91 <0.01 0.001
Collinsella Blood CD8+ 0.83 <0.01 0.016
Collinsella Blood CD4+ 0.89 <0.01 0.002
 PCD7 Clostridiales (unclassified) Ileum CD8+ 0.89 <0.01 0.002
Mycoplasmataceae (unclassified) Ileum CD8+ 0.80 0.01 0.021
Negative correlations
 PCD0 Clostridium Ileum CD8+ −0.90 <0.01 0.002
Anaerococcus Ileum CD8+ −0.88 <0.01 0.002
Propionibacterium Blood CD8+ −0.88 <0.01 0.002
Bacillales (unclassified) Blood CD8+ −0.87 <0.01 0.003
Blautia Blood CD8+ −0.81 <0.01 0.009
Clostridium Ileum CD4+ −0.83 <0.01 0.013
Anaerococcus Ileum CD4+ −0.86 <0.01 0.006
Clostridiales (unclassified) Blood CD4+ −0.89 <0.01 <0.01
Clostridiales (unclassified) Blood CD4+ −0.82 <0.01 0.014
 PCD7 Anaerococcus Ileum CD8+ −0.84 <0.01 0.010
Anaerococcus Spleen CD8+ −0.83 <0.01 0.016
Anaerococcus Spleen CD4+ −0.87 <0.01 0.005
Staphylococcus Spleen CD4+ −0.81 <0.01 0.020
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Histopathologic parameters did not differ between the 
groups. Our Gn pig model did not exhibit small intestinal 
villous blunting, crypt hyperplasia, or lymphocytic infil-
tration, which are the histologic lesions of EED. The pigs 
also did not have microscopic lesions of rotavirus infec-
tion, the lack of which may be partially due to timing. At 
PCD7, the small intestine has recovered from rotavirus 
infection and there are no histopathologic lesions in Gn 
pigs [15]. Although the nutritional status of the pigs was 
not assessed in this study, the lack of significant differ-
ences in body weights between the groups suggests that 
nutrient assimilation was not altered. We can speculate 
that other factors such as malnutrition or concurrent 
enteropathogen infections are needed to induce the EED 
phenotype. Additionally, 6 weeks may not have provided 
sufficient time to develop EED; however it is logistically 
difficult to keep Gn pigs for extended periods of time.
A recent paper describing a Gn mouse model of EED 
demonstrated that both malnutrition and gut micro-
biome were key to developing the model [34]. Our pigs 
received a nutritionally adequate diet. Thus, we suspect 
incorporation of malnutrition, and potentially enter-
opathogens into our dysbiosis model will be required to 
establish a Gn pig model of EED. A mouse study dem-
onstrated that protein-energy malnutrition alone does 
not impair vaccine efficacy or increase the severity of 
infection [35]. Another recent paper showed that EED, 
systemic inflammation, and poor maternal health were 
associated with underperformance of oral rotavirus vac-
cine (Rotarix®) and oral poliovirus vaccine but not par-
enteral vaccines in Bangladeshi children [11]. Systemic 
inflammation and poor maternal health were also predic-
tive of malnutrition [11]. In the future, we can use the Gn 
pig model to address effects of malnutrition and systemic 
inflammation on gut immunity.
In future studies, if we succeed in creating histologic 
changes and altered biomarker concentrations in our 
attempt to create an enteropathy pig model, additional 
assays can be utilized to further characterize the model. 
Tight junction and adherens junction proteins such as 
occludin, claudins, E-cadherin, and catenins can pro-
vide further insight into intestinal permeability. Sys-
temic inflammation can be assessed with cytokines and 
acute phase proteins such as IL-1β, IL-4, IL-5, TNFα, 
C reactive protein (CRP), ferritin, and soluble CD14 
(sCD14) [11]. Endotoxin core antibody IgG (Endocab) 
in serum can be used to evaluate bacterial transloca-
tion as well as systemic inflammation [9]. The lactu-
lose to mannitol ratio assay is a standard test used in 
children to assess intestinal permeability and impaired 
tight junctions [9]. We did not utilize this test as the 
requirement for 2–5  h urine collection and the need 
to use a closed urinary collection system in the pigs is 
not technically feasible with gnotobiotic pig isolators or 
behavior of pigs [9].
There are limitations to this study. Due to the size 
and weight constraints of the pig isolators, long-term 
studies are not feasible. This limitation did not allow us 
to determine if structural or functional changes occur 
after a longer time period. Regarding the HGM, we 
used one HHGM and one UHGM sample, both from 
breastfed, vaginally delivered, Nicaraguan children liv-
ing in homes with piped water and indoor toilets. As 
stated previously, numerous factors contribute to gut 
microbiome composition and environmental enter-
opathy. We do not know if the same results would be 
obtained with different HHGM and UHGM samples. 
Ideally, future studies will evaluate multiple HHGM 
and UHGM from children exposed to different vari-
ables such as diet, access to clean water, method of 
delivery and country of habitation with equal numbers 
of male and female samples. Despite the limitations, 
the Gn pig model of dysbiosis provides a valuable tool 
for future studies to investigate the immunomodulating 
mechanisms of the gut microbiota on the immune sys-
tem and disease pathogenesis.
Further studies are needed to characterize the roles of 
specific bacterial species on enteric immunity and rota-
virus infectivity. Additionally, by adding malnutrition and 
enteropathogens to this model, we may be able to reca-
pitulate EED. A pig model of EED and rotavirus vaccina-
tion will be valuable since mouse models of subclinical 
enteric viral infections often do not predict vaccine effi-
cacy against disease in humans. Rotavirus pathogenesis 
and immunity are similar in pigs and humans, but differ-
ent in mice [36].
Table 4 Characterization of  HGM samples used for  oral 
inoculation of Gn pigs
SV14 (healthy gut) PM25 (unhealthy gut)
Enteropathy score 4 11
Myeloperoxidase 0.37 μg/ml 2.08 μg/ml
α‑1‑antitrypsin 22.9 μg/ml 141.4 μg/ml
Neopterin 74.7 nmol/l 412.4 nmol/l
Calprotectin 148.5 μg/g 220.6 μg/g
Pre‑vaccination IgA titer 1:20 1:50
Post‑vaccination IgA titer 1:3200 1:100
Fold increase in IgA titer 160 2
Phylogenetic diversity 7.8 5.7
Shannon Index 4 3.3
Observed species 107.4 67.3
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Conclusions
We established a HGM transplanted Gn pig model of 
dysbiosis and evaluated the influence of the gut microbi-
ota on vaccine immunogenicity and microbiota response 
to VirHRV challenge. We demonstrated that impaired 
enteric immunity in human infants can be recapitulated 
in the Gn pig model with UHGM transplantation. Our 
findings indicate that the gut microbiota has a major 
impact on vaccine immunogenicity. This animal model 
will be valuable in the evaluation of various strategies 
(i.e. probiotics, prebiotics, nutritional supplementa-
tion) to modulate the intestinal microbiome in order to 
enhance the immune responses to rotavirus vaccine as 
well as other vaccines, and enteropathogens such as nor-
ovirus, enterotoxigenic E. coli and Shigella. Results from 
this study provide a stepping stone for further research 
involving influence of specific bacterial species on enteric 
immunity and interaction with rotavirus. Additionally, by 
adding additional factors to this model such as malnutri-
tion, it may be possible to emulate EED. Enteric dysbiosis, 
malnutrition, and EED interact in a complex and ill-
defined way to negatively impact the health and immu-
nity of young children in the developing world, leading to 
widespread morbidity and likely increased mortality.
Methods
Stool samples for HGM transplantation
Stool samples were obtained and analyzed from infants as 
described in a previous manuscript [37]. Briefly, infants 
from León, Nicaragua were recruited one day prior to 
their first pentavalent rotavirus (RV5) immunization, had 
blood drawn and a stool sample collected from a soiled 
diaper. A second blood sample was collected 1  month 
after the first dose of vaccine. Stool specimens were 
diluted 20-fold and homogenized in sterile pre-reduced 
anaerobic saline-0.1  M potassium phosphate buffer (pH 
7.2) containing 15% glycerol (v/v). The samples were 
snap frozen in liquid nitrogen in the field, immediately 
transferred to −80 °C, shipped on dry ice to our lab, and 
stored at −80 °C until assayed. All stool samples under-
went 16S rRNA amplicon sequencing for characteriza-
tion of the gut microbiome, as previously described [25]. 
ELISAs for 4 biomarkers of enteropathy (α−1 antitrypsin, 
neopterin, myeloperoxidase and calprotectin) were run 
on the samples [38, 39]. Results from each marker were 
divided into quantiles with 1 assigned to first quantile, 2 
for second quantile, 3 for third quantile and 4 for fourth 
quantile. The numbers were then added to create a com-
bined enteropathy score (ES) for these 4 biomarkers 
ranging from 4 to 16. Rotavirus-specific serum IgA titers 
were measured on all blood samples. Results of the infant 
studies were detailed in a previous publication [37]. Com-
pared to infants who seroconverted, infants who did not 
seroconvert had higher concentrations of both myelop-
eroxidase and calprotectin in stool samples, and higher 
mean ES. The UHGM sample (ID PM25) was collected 
from a 9-week old female child with poor seroconver-
sion to the RV5 vaccine, high ES and low alpha diversity 
(AD). Conversely, the HHGM sample (ID SV14) was col-
lected from an 8-week old male child with a strong IgA 
response to the RV5 vaccine, low ES, and high AD. The 
parameters for each variable in the two samples are listed 
in Table 4. The composition of the microbiome for each 
sample is shown in Fig. 8. Both children were delivered 
vaginally and breastfed. They came from different homes; 
both homes had municipal indoor piped water and 
indoor toilets.
Studies were approved by the Office of Human 
Research Ethics at the University of North Carolina 
(UNC) at Chapel Hill (#14-1136) and the Universidad 
Nacional Autónoma de Nicaragua, León (#110). Par-
ents or legal guardians of the infants provided written 
consent.
Selection and preparation of infant samples for HGM Gn 
pig transplantation
The UHGM stool sample was selected from an infant 
who did not seroconvert following receipt of the first 
dose of RV5 (seroconversion defined as >4-fold increase 
in rotavirus-specific serum IgA titers 1  month after 
RV5 immunization), low phylogenetic diversity of the 
gut microbiome, and high ES. The HHGM stool sample 
was selected from a child with high RV5 immunogenic-
ity (experienced a  >4-fold increase in rotavirus-specific 
serum IgA titers after RV5 immunization), high phyloge-
netic diversity of the gut microbiome, and low ES.
The selected HGM were screened and confirmed 
negative for rotavirus, astrovirus, norovirus, sapovirus, 
adenovirus, and Klebsiella spp. via PCR prior to oral 
transplantation into the Gn pigs. Klebsiella spp. were 
specifically targeted because previous studies have lost 
HGM transplanted pigs to Klebsiella infection from the 
inocula [20, 40]. Primers for the Klebsiella spp. PCR tar-
geted the gyrA gene and were based on previous publica-
tions [41, 42]. The universal 16S rRNA primers, 27F and 
1492R were included in the PCR protocol to confirm the 
presence of amplifiable DNA. DNA was extracted with 
ZR Fecal DNA MiniPrep (Zymo, Irvine, CA) from 150 µl 
of sample per manufacturer’s instructions. Klebsiella 
pneumoniae, obtained from the Virginia Tech Animal 
Laboratory Services bacteriology laboratory was used 
as a positive control sample. The master mix contained 
5  µl PFX 50 PCR mix, 1  µl PFX 50 DNA polymerase 
(ThermoFisher Scientific, Waltham, MA), 1.5 µl 10 mM 
dNTPs, 1.5 µl of each primer (10 μM), 4–30 µl of DNA 
and water added to a final volume of 50 µl. After a 2-min 
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incubation at 94  °C, 35 cycles of 94  °C 15 s, 60  °C 20 s, 
and 68  °C 1  min were performed, followed by a final 
extension at 68 °C for 5 min.
PCR for norovirus genogroups I and II, adenovirus, 
sapovirus, and astrovirus were carried out at St. Jude 
Children’s Research Hospital. DNA and RNA were 
extracted from 175 µl of sample using the MagMax Total 
Nucleic Acid isolation kit (ThermoFisher Scientific). PCR 
buffer for the RNA samples was Taqman fast virus 1-step 
(ThermoFisher Scientific). Taq core kit (Qiagen, Valen-
cia, CA.) was used for DNA samples. Norovirus I and 
II, sapovirus, adenovirus, and astrovirus real-time PCR 
primers, as well as, probes and conditions, were based on 
previous publications [43–46].
RT-PCR for rotavirus gene segment 6 was used to 
screen samples for rotavirus. RNA was extracted from 
samples using TRIZOL LS (ThermoFisher Scientific) per 
manufacturer’s instructions. The mixture for cDNA syn-
thesis included 2 µmol of primer 1581, and 11 µl of RNA. 
RNA was denatured at 95  °C for 5  min then cooled to 
4 °C. The mixture for reverse transcription contained 4 µl 
of 5× buffer, 1 µl 0.1 M DTT, 1 µl Superscript III reverse 
transcriptase (ThermoFisher Scientific) and 1 µl of RNase 
free water. The cDNA sample was combined with the 
mixture for reverse transcription and incubated at 50 °C 
for 60 min then 70 °C for 15 min and held at 4  °C. One 
microlitre of RNaseH (New England Biolabs, Ipswich, 
MA) was added and the sample was incubated at 37  °C 
for 20 min. The PCR mix contained 10 µl of buffer, 1 µl 
of MyTaq DNA polymerase (Bioline, Taunton, MA), 27 µl 
of ddH2O, 1 µl of each 20 μM primer (158 (forward) and 
15 (reverse), and 10 µl of DNA. The sequence for primer 
158 was GGC TTT AAA ACG AAG TCT TCG AC and 
that for primer 15 was GGT CAC ATC CTC TCA CTA. 
The sample was incubated at 95 °C for 3 min followed by 
35 cycles of 95 °C 20 s, 47.5 °C 30 s, and 72 °C 90 s. Final 
extension was at 72 °C for 7 min. AttHRV was used as a 
positive control.
HGM was prepared for oral inoculation into the Gn 
pigs as described previously [20]. The sample was washed 
with tenfold volume of sterile PBS to remove glycerol, 
and then centrifuged at 2000  rpm for 10  min at 4  °C. 
The pellet was resuspended to the original volume with 
sterile PBS. Pigs received 400–700 µl of HGM sample at 
5–7 days of age.
Pig studies
Near-term pigs (Yorkshire crossbred) were derived by 
hysterectomy and maintained in sterile isolator units as 
described previously [47]. The estimated sample size to 
Fig. 8 Composition of human infant microbiome samples used to inoculate Gn pigs. UM indicates unclassified member. Relative abundance is on 
the y‑axis
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obtain greater than 0.9 power is n ≥ 6 based on a power 
analysis using an ANOVA or ANCOVA model by the 
Virginia Tech Department of Statistics. Sterility was con-
firmed by culturing isolator swabs and porcine rectal 
swabs on blood agar plates and in thioglycollate media 
3  days after derivation. Commercial ultra-high temper-
ature-treated sterile cow milk was used throughout the 
study. The pigs were housed with a 12-h light–dark cycle 
at 80–93  °F (based on age) and provided with a toy for 
environmental enrichment. The animal experimental 
protocol is outlined in Additional file 1: Table S1. These 
pigs and data generated from them have not been used 
in previous publications. In total, 24 pigs were randomly 
assigned to the 4 groups (HHGM-PID28/PCD0 n  =  5, 
HHGM PCD7 n  =  7, UHGM PID28/PCD0 n  =  6 and 
UHGM PCD7 n =  6). Intraperitoneal (IP) injections of 
gamma-irradiated, commercially available porcine serum 
(Rocky Mountain Biologicals Inc., Missoula, MT) were 
given to the pigs in an attempt to provide immunoprotec-
tion against potentially pathogenic bacteria in the HGM 
transplants. A total volume of 60 ml was given at 3 time 
points, 6 h apart, starting on the day of or day after deri-
vation. In the commercial serum, rotavirus-specific virus 
neutralization titer was measured at 64, rotavirus-spe-
cific IgG titer at 65,536, and rotavirus-specific IgA titer 
at 64. At PCD 0, the geometric mean titers for rotavirus-
specific antibodies among all pigs were 16.7 for virus 
neutralizing antibodies, 10,935 for IgG, and 75.9 for IgA. 
These titers mimic normal maternally acquired rotavirus 
antibody titers in conventionally derived suckling pigs 
or human infants [48]. The cell culture-adapted HRV 
Wa strain (G1P1A [8]), derived from the 35th passage in 
African green monkey kidney cells (MA104), was used 
as the AttHRV vaccine for oral inoculation at a dose of 
5 ×  107 focus-forming units (FFU) on PID 0 (7  days of 
age), PID10 and PID20 [17]. A subset of pigs (n = 5–6) 
from each group was euthanized before challenge PID28/
PCD0 for evaluation of immune responses induced by 
AttHRV vaccination. The remaining pigs (n = 6–7) were 
orally challenged with 105 FFU of VirHRV Wa strain 
(G1P1A [8]) and monitored from PCD0-PCD7 to evalu-
ate virus shedding and diarrhea before euthanasia on 
PCD7. The 50% infectious dose (ID50) of VirHRV in neo-
natal Gn pigs is approximately 1 FFU [15]. Rectal swabs 
were collected daily to monitor virus shedding by ELISA 
and CCIF from PCD0-PCD7. Daily diarrhea scoring was 
defined as (0) solid, (1) pasty, (2) semi-liquid, or (3) liq-
uid. Scores of 2 or higher represented diarrhea.
All animal protocols were approved by the Institu-
tional Animal Care and Use Committee at Virginia Tech 
(protocol #13-187-CVM) and performed in accordance 
with federal and university guidelines, as well as with 
recommendations in the American Veterinary Medical 
Association Guidelines for the Euthanasia of Animals. All 
sow surgeries were performed under ketamine and tile-
tamine-zolazepam anesthesia, and immediately followed 
by euthanasia. A lidocaine epidural was administered 
preoperatively.
Rotavirus‑specific serum and intestinal antibody titers
Pigs were bled and weighed weekly starting at 7  days 
of age (PID 0). The LIC and SIC were collected at nec-
ropsy. Determination of rotavirus-specific IgA and IgG 
antibody titers in serum and SIC, and IgA in LIC, were 
based on previously described methods [16, 49]. Briefly, 
96-well microtiter plates were coated with semi-purified 
AttHRV antigen at 1:60 or mock-infected MA104 cell 
culture control lysate at 1:60 in 0.05 M carbonate buffer 
pH 9.6 overnight at room temperature. The plate was 
washed with TBS pH 8.0 with 0.05% Tween (TBST) five 
times. Plates were blocked with TBS containing 1% BSA 
for 1 h at room temperature. Four-fold serial dilutions of 
each sample in TBST containing 1% BSA were performed 
on a separate plate. The samples were then transferred to 
the antigen-coated plate and incubated for 2  h at room 
temperature followed by five washes with TBST. Plates 
were then incubated for 1  h at room temperature with 
the detection antibody. The IgA assay used goat anti-
porcine IgA polyclonal HRP-conjugated antibody (A100-
102P, Montgomery, TX; AB_67219) and the IgG assay 
used goat anti-porcine IgG-Fc fragment polyclonal HRP-
conjugated antibody (A100-104P, Bethyl Laboratories, 
Inc.; AB_67225). Both antibodies were diluted 1:35000 in 
TBST containing 1% BSA. Plates were washed five times 
with TBST and developed with ABTS (2,2′-azino-di(3-
ethylbenzothiazoline-6-sulfonate) HRP substrate (KPL, 
Inc., Gaithersburg, MD) for 15–30 min at room tempera-
ture. The reaction was stopped with ABST peroxidase 
stop solution (KPL, Inc.) diluted 1:5 in water. Optical 
density was measured at 405 nm.
Rotavirus‑specific serum virus neutralizing antibody titer
African green monkey kidney cells, MA104 (ATCC, 
Manassas, VA, # CRL-2378.1, purchased from ATCC in 
January 2008) were grown in 96-well plates for 3–4 days. 
Monolayers were washed once with Eagle’s minimum 
essential medium (EMEM) (ATCC), and 100 µl of EMEM 
was added to each well. The plate was incubated at 37 °C 
for 2 h. In a separate 96-well plate, serum samples were 
diluted 4-fold in duplicate. One set of each sample was 
inoculated with AttHRV (4 × 103 FFU) and the other set 
with EMEM. This plate was incubated at 37  °C for 1  h. 
After the 2  h incubation, EMEM in the MA104 plates 
was discarded and the cells were incubated with 50  µl/
well of the serum with AttHRV or EMEM in duplicate 
at 37  °C for 1  h. Fifty microlitre of EMEM with trypsin 
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(0.5  μg/ml) was added to each well and the plate was 
incubated at 37  °C with 5% CO2 for 18–24  h. Liquid in 
the wells was discarded and the plates were fixed with 
80% acetone at room temperature for 10  min. Acetone 
was discarded and plates were air-dried. Fixed plates 
were stored at −20 °C or stained immediately. For immu-
nofluorescence staining, plates were initially rinsed with 
PBS containing 0.05% Tween 20 (PBST) pH7.4 once for 
2 min. Each well received 50 µl of goat anti-bovine rota-
virus polyclonal unconjugated antibody (PA1-7241, Ther-
moFisher Scientific; AB_561090) diluted 1:250 in PBST 
containing 2% nonfat dry milk then incubated at 37 °C for 
1  h. Plates were rinsed 3 times with PBST. Fifty micro-
litre of rabbit anti-goat IgG whole molecule polyclonal 
FITC-conjugated antibody (F7367, Sigma-Aldrich, St. 
Louis, MO; AB_259726) diluted 1:400 in PBST contain-
ing 2% nonfat dry milk was added to each well and incu-
bated at 37 °C for 1 h. Plates were rinsed 3 times with PBS 
pH 7.4 and once with PBS pH8.0. Mounting media (60% 
glycerol, 40% PBS pH 8.0) was added to each well. Fluo-
rescing cells were enumerated by fluorescent microscopy. 
The virus neutralizing antibody titer was defined as the 
reciprocal of the serum dilution which reduced the num-
ber of fluorescent cell forming units by >80% [50].
CCIF and rotavirus antigen ELISA
Rectal swabs were processed as reported in a previous 
study [51]. Briefly, two rectal swabs per pig were rinsed 
in 8  ml diluent #5 (minimal essential media (MEM, 
ThermoFisher Scientific) 1% penicillin and streptomy-
cin, 1% HEPES) and then centrifuged at 2100  rpm for 
15 min at 4   °C. Viral antigen and infectious virus in the 
rectal swabs were measured using ELISA or cell culture 
immunofluorescence (CCIF), respectively, as previously 
described [52].
The CCIF was performed in MA104 cells grown in 
96-well plates for 3–4 days. Plates were washed with PBS. 
One hundred microlitre of EMEM was added to each 
well and the plate was incubated for 2  h at 37   °C with 
5% CO2. In separate 96-well plates, tenfold serial dilu-
tions of the samples were made in EMEM. After the plate 
with cells was removed from the incubator, media was 
discarded. Fifty microlitre from each well on the dilu-
tion plate was added to the cells in duplicate. The plate 
was centrifuged at 2000  rpm for 1 h at 21  °C with slow 
deceleration. EMEM containing trypsin was then added 
to each well for a final trypsin concentration of 0.5 µg/ml. 
The cells were incubated at 37  °C for 18–24 h in a CO2 
incubator. The protocol for acetone fixation and immu-
nofluorescence staining of the plates was the same as 
described for the neutralizing antibody titer assay.
Using ELISA to detect rotavirus antigen, a 96-well 
microtiter plate was coated with 100  µl/well goat 
anti-bovine rotavirus polyclonal unconjugated antibody 
(PA1-7241, ThermoFisher Scientific; AB_561090) in 
0.05 M carbonate buffer pH 9.6 at a dilution of 1:250. The 
plates were incubated overnight at 4  °C. Plates were then 
washed twice with PBST, blocked with 300 µl/well of PBS 
pH 7.4 containing 5% nonfat dry milk then incubated 
for 1 h at 37  °C. Plates were washed 3 times with PBST. 
One hundred microlitre/well of diluted sample (in PBS 
with 0.1% BSA) was added in duplicate. Semi-purified 
AttHRV antigen or supernatant of mock-infected MA104 
cells were used as a positive and negative control respec-
tively. Plates were incubated for 1 h at 37  °C then washed 
3 times with PBST. One hundred microlitre/well of goat 
anti-bovine rotavirus polyclonal HRP-conjugated anti-
body (PA1-73015, ThermoFisher Scientific; AB_1018382) 
diluted 1:200 in PBS containing 1% BSA was then added 
to each well and incubated for 1 h at 37  °C, followed by 3 
washes with PBST. One hundred microlitre/well of ABST 
peroxidase substrate solution was added and the plate 
was incubated for 15–30 min at room temperature. The 
reaction was stopped with 100 µl/well of ABST stop solu-
tion diluted 1:5. The optical density values were meas-
ured at 405 nm.
Mononuclear cell isolation
Mononuclear cells (MNC) were isolated from the ileum, 
spleen, and blood as described in previous publica-
tions [17, 18, 53]. Briefly, after rinsing the ileum sam-
ples with HBSS without Ca2+ and Mg2+ (GE Healthcare, 
Logan, UT), they were manually minced with scissors, 
resuspended in 40  ml solution A (HBSS without Ca2+, 
Mg2+  with 200  μg/ml gentamicin, 20  μg/ml ampicil-
lin, 40  mM HEPES, 5  mM EDTA, 0.29  mg/ml DTT, 
and 7% NaHCO3) then placed on a shaker at 37  °C for 
30 min. Tissue fragments were further minced and solu-
tion C (RPMI-1640 (ThermoFisher Scientific) with 8% 
FBS, 200 μg/ml gentamicin, 20 μg/ml ampicillin, 20 mM 
HEPES, 5  mM EDTA, 0.29  mg/ml DTT, and 400  U/ml 
collagenase type II (Worthington Biochemical Co, Lake-
wood, NJ) was added to 40 ml and digested at 37  °C for 
30 min with shaking. Supernatants were collected and 
remaining tissue was ground on an 80–mesh screen. 
The cell suspension was collected and the remaining 
tissue underwent another digestion step with repeated 
grinding on the screen. Cell suspensions were divided 
equally between three 50  ml conical vials and wash 
media (RPMI-1640 with 200  μg/ml gentamicin, 20 ug/
ml ampicillin, and 10  mM HEPES) was added to a vol-
ume of 35 ml. Percoll (GE Healthcare) was added to each 
tube to bring the final Percoll concentration to 30% and 
then centrifuged at 1800g for 20 min at 4  °C without the 
brake. Cell pellets were resuspended in 15  ml conical 
vials with 10  ml of 43% Percoll, underlaid with 5  ml of 
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70% Percoll, and centrifuged at 1800g for 30 min at 4  °C 
without brake. MNC were collected from the 43 to 70% 
Percoll interface into 50  ml conical vials with 50  ml of 
wash buffer and centrifuged at 800g for 15 min at 4 °C.
Blood was mixed with 30% (vol/vol) of acid citrate dex-
trose at the time of necropsy, divided equally between 
three 50  ml conical vials with HBSS added to bring the 
volume to 50  ml, and then centrifuged for 30  min at 
1200g with no brake at room temperature. The buffy 
coat was transferred to a 50  ml conical vial with HBSS 
added to a volume of 30  ml. The buffy coat mixture is 
then divided equally among three 15 ml centrifuge tubes, 
underlaid with 5  ml of Ficoll-Paque PREMIUM® (GE 
Healthcare Bio-Sciences, Pittsburgh, PA) and centri-
fuged at 1200g for 30 min at room temperature with no 
break. MNC were collected from the interface, placed in 
a 50 ml vial, HBSS added to bring the volume to 30 ml, 
and then centrifuged for 15 min at 800g 4 °C. Remaining 
erythrocytes were lysed by mixing 5 ml of sterile distilled 
water with the cell pellet, after which HBSS was added to 
a final volume of 50 ml. The samples were centrifuged for 
15 min at 400g 4 °C, after which the HBSS wash and cen-
trifugation step was repeated.
The spleens were minced and ground as described for 
the ileum without the solution C step. Cells were sus-
pended in 50  ml of wash media then centrifuged for 
30  min 1000g 4  °C. The cell pellet was resuspended in 
20 ml of wash buffer and then Percoll was added to bring 
the final Percoll concentration to 30%. Samples were cen-
trifuged for 1200g 4  °C without brake. Cells were resus-
pended with 30  ml of 43% Percoll, divided into three 
15 ml tubes, underlaid with 5 ml of 90% Percoll and then 
centrifuged for 30  min at 1900g for 30  min 4  °C with-
out the brake. MNC were collected at the 43–70% Per-
coll interface into a 50 ml conical vile with wash buffer, 
centrifuged for 15  min at 504g for 15  min 4  °C twice, 
changing the wash buffer between steps. MNC from 
all tissues were resuspended with 2–10  ml of enriched-
RPMI (RPMI-1640 with 20 mM HEPES, 100 μg/ml gen-
tamicin, 10 μg/ml ampicillin, 8% FBS, 2 mM l-glutamine, 
0.1  mM nonessential amino acids, 1  mM sodium pyru-
vate, and 50 mM 2-mercaptoethanol.
Flow cytometry for rotavirus‑specific IFN‑γ producing T 
cells
Frequencies of HRV-specific IFN-γ producing CD4+ and 
CD8+  T cells among the lymphocytes of the ileum, 
spleen, and blood were determined with flow cytome-
try. MNC were stimulated in 12-well culture plates with 
12  μg/ml of semi-purified AttHRV antigen for 17  h at 
37  °C in a CO2 incubator. Brefeldin A (Sigma-Aldrich) 
at 5 mg/ml, and mouse anti-human CD49d monoclonal 
APC-conjugated antibody (561892, BD Biosciences, San 
Jose, CA; AB_10896134) at 1 µg/ml were added at hour 
12 of the incubation. MNC were washed with staining 
buffer (3% FBS and 0.09% sodium azide in DPBS (0.2 mg/
ml KCl, 0.2 mg/ml KH2PO4, 8 mg/ml NaCl and 2.16 mg/
ml Na2HPO4·7H2O, pH 7.2–7.4) and centrifuged at 500g 
for 5  min 4  °C. The MNC (2 ×  106  cells/tube in 100  µl 
staining buffer) were stained at 4  °C for 15  min using 
the following monoclonal antibodies: (1) One microli-
tre mouse anti-porcine CD4a monoclonal FITC-conju-
gated antibody, clone 74-12-4 (559585, BD Biosciences; 
AB_397279), (2) 0.5  µl mouse anti-pig CD8α monoclo-
nal SPRD-conjugated antibody, clone 76-2-11 (4520-13, 
SouthernBiotech, Birmingham, AL) and (3) 2 µl of mouse 
anti-pig CD3ε monoclonal UNLB-conjugated anti-
body, clone PPT3 (4510-01, Southern Biotech) and then 
washed with staining buffer. Next the MNC were centri-
fuged at 500g for 5 min, followed by the addition of 1 µl 
of rat anti-mouse IgG1 monoclonal APC-conjugated anti-
body, clone ×56 (550874, BD Biosciences; AB_398470) 
to the samples and stained for 15 min at 4  °C, and then 
washed with staining buffer. Samples were centrifuged 
at 500g for 5  min. One hundred microlitre of Cytofix/
Cytoperm (BD Biosciences) was added to the sam-
ples, which were then incubated for 30 min at 4  °C and 
washed once with Perm/Wash buffer (BD Biosciences). 
Next, 1 µl of mouse anti-pig IFN-γ monoclonal PE-con-
jugated antibody, clone P2G10 (559812, BD Biosciences; 
AB_397341) was added and the samples were incubated 
at 4 °C for 30 min. The samples were washed with Perm/
Wash buffer solution, centrifuged at 500g for 5 min and 
then had 0.25  ml of staining buffer added. A minimum 
of 100,000 events were acquired using a FACSAria sorter. 
Flow cytometry data were analyzed using FlowJo 7.2.2 
software (Tree Star, Ashland, OR).
DNA isolation and 16S rRNA amplicon sequencing
LIC were collected at necropsy, snap frozen in liquid 
nitrogen and shipped on dry ice to the UNC Microbi-
ome Core Facility where 16S rRNA amplicon sequenc-
ing DNA isolation was carried out as described [25]. 
Briefly, samples (200 mg) were transferred to sterile 2 ml 
tubes containing 200  mg of 212–300  μm glass beads 
(Sigma-Aldrich) and 1.4  ml of Qiagen ASL buffer for 
bead beating and subsequently incubated at 95  °C for 
5  min. Supernatants were treated with InhibiEx inhibi-
tor adsorption tablets (Qiagen) to remove PCR inhibi-
tors. After a brief centrifugation, supernatants were 
transferred to a new tube with Qiagen AL buffer con-
taining Proteinase K (600 IU/μl) and incubated at 70 °C 
for 10 min. DNA was purified using Zymo-spin columns 
(Genesee Scientific, Morrisville, NC) and Qiagen buffers 
AW1 and AW2 as washing agents, and eluted in 10 mM 
Tris (pH 8.0).
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Sequencing libraries were prepared from total DNA 
(12.5 ng) amplified using a combination (4:1) of Univer-
sal and Bifidobacterium-specific primers targeting the 
V1–V2 region of the bacterial 16S rRNA gene [54–56]. 
Primers contained overhang adapters for compatibility 
with the Illumina sequencing platform and sequenc-
ing adapters. Master mixes contained 12.5  ng of total 
DNA, 0.2 µM of each primer and 2× KAPA HiFi Hot-
Start ReadyMix (KAPA Biosystems, Wilmington, MA). 
Amplicons were purified using the AMPure XP reagent 
(Beckman Coulter, Indianapolis, IN) and then ampli-
fied using a limited cycle PCR program, adding Illu-
mina sequencing adapters and dual‐index barcodes 
[index 1(i7) and index 2(i5)] (Illumina, San Diego, CA) 
to the amplicon target. Final libraries were purified, 
quantified and normalized prior to pooling. The DNA 
library pool was then denatured with NaOH, diluted 
with hybridization buffer, and heat denatured before 
loading on the MiSeq reagent cartridge (Illumina) and 
on the MiSeq instrument (Illumina). Automated clus-
ter generation and paired–end sequencing with dual 
reads were performed according to the manufacturer’s 
instructions.
Sequencing data analysis
Multiplexed paired-end fastq files were generated from 
sequencing data using the Illumina software configureB-
clToFastq. The paired-end fastqs were then joined into 
a single multiplexed, single-end fastq using the software 
tool fastq-join. Demultiplexing and quality filtering was 
performed on the joined results and quality analysis 
reports were produced using the FastQC software. Sub-
sequent analyses were performed using the Quantitative 
Insights Into Microbial Ecology (QIIME v.1.8.0) [57] as 
described [25, 58]. Sequences were clustered into opera-
tional taxonomic units (OTU) at 97% similarity thresh-
old using UCLUST [59], and they were aligned in order 
to build a phylogenetic tree [60]. A random selection 
of 1118 sequences from each sample was used for rar-
efaction analysis to determine diversity using observed 
species (S) and phylogenetic diversity (PD) metrics on 
rarefied OTU tables. Beta diversity and principal coordi-
nates analysis (PCoA) were calculated using unweighted 
UniFac distances between samples at a depth of 1118 
sequences per sample. Taxa of the L6 OTU (genus level) 
table with a relative abundance of 0.5% or greater and all 
taxa of the L2 OTU (phylum level) table were compared 
between groups at PCD0 and PCD7. Alpha diversity was 
compared in a similar fashion. Spearman’s rank correla-
tion coefficients were determined between the frequen-
cies of T cells in the ileum, blood and spleen of all pigs 
and taxa of the L6 and L2 OTU tables at PCD0 and 
PCD7.
Histopathology
Sections of duodenum, jejunum, and ileum were col-
lected, routinely processed, and analyzed as previously 
described [51]. The pathologist, blinded to the animal 
identification, evaluated villus length, crypt depth, villus-
to-crypt ratio, crypt mitotic index, and lamina propria 
width.
Enteropathy biomarkers
Large intestinal contents collected at necropsy were 
used for biomarker evaluation using commercial por-
cine ELISA kits (α-1-antitrypsin, TSZ ELISA, BIOTANG 
Inc. Lexington, MA; Reg1B, Elabsceince, Wuhan, Hubei, 
China; myeloperoxidase, MyBioSource, San Diego, CA). 
Assays were run per manufacturer’s instructions.
Statistical analysis
Kruskal–Wallis rank sum test was used for comparisons 
of rotavirus-specific antibody titers in serum, LIC and 
SIC, frequencies of IFN-γ producing T cells, enteropathy 
biomarkers measured in pigs, histopathology, diarrhea 
duration and score, virus shedding duration and titer, and 
comparisons of microbiome composition between HGM 
groups. Fisher’s exact test was used for comparisons of 
percentages of virus shedding and diarrhea. The correla-
tions between T cell frequencies in the ileum, blood and 
spleen of all pigs, and taxa of the L6 OTU table at PCD0 
and PCD7 were determined by Spearman’s rank cor-
relation analysis with the Benjamini-Hochberg method 
for false detection rate. Correlations were considered 
strongly negative or positive if ρ < −0.8 or ρ > 0.8, respec-
tively. Statistical significance was assessed at p < 0.05.
Additional files
Additional file 1: Table S1. Experimental design for Gn pig study. Table 
S2. Mean concentration of specified enteropathy biomarkers in large 
intestinal contents on PID28 and PCD7. Table S3. Mean measurements 
per group for specified parameter and tissue. V:C is the villous to crypt 
ratio. Mitotic index was determined by counting mitotic figures in 50 
crypts. Measurements are given in mm. Table S4. Weights (in kg) of Gn 
pigs during the study.
Additional file 2: Figure S1. Duodenum Histopathology. Representa‑
tive photomicrographs of duodenum sections from a pig in each group 
at each time point. A. HHGM PID 28, B. HHGM PCD 7, C. UHGM PID28, D. 
UHGM PCD7. There are no significant histologic differences between the 
groups. Scale bar is 200 μm.
Additional file 3: Figure S2. Jejunum Histopathology. Representative 
photomicrographs of jejunum sections from a pig in each group at each 
time point. A. HHGM PID 28, B. HHGM PCD 7, C. UHGM PID28, D. UHGM 
PCD7. There are no significant histologic differences between the groups. 
Scale bar is 200 μm.
Additional file 4: Figure S3. Ileum Histopathology. Representative 
photomicrographs of ileum sections from a pig in each group at each 
time point. There are no significant histologic differences between the 
groups. A. HHGM PID 28, B. HHGM PCD 7, C. UHGM PID28, D. UHGM PCD7. 
Scale bar is 200 μm.
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